Clinical Trials Directory

Trials / Completed

CompletedNCT00828269

Evaluation of RNA From the Liver Tissue Obtained in Patients With Chronic Hepatitis C (0000-123)

Evaluation of RNA Quality and the Reproducibility of Gene Expression Profiling From Liver Tissue Obtained by Fine Needle Aspiration in Patients With Chronic Hepatitis C.

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
12 (actual)
Sponsor
Merck Sharp & Dohme LLC · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the quality of the RNA and the reproducibility of gene expression profiling from liver tissue samples obtained by fine needle aspiration.

Conditions

Interventions

TypeNameDescription
PROCEDUREComparator: Fine needle aspiration biopsyVisit 1: Screening Visit 2 (7-14 days from screening): Core needle biopsy and fine needle aspiration biopsy - liver. Visit 3:(7 days from visit 2): Fine needle aspiration biopsy - liver. Visit 4: (14 days from Visit 3): follow-up visit

Timeline

Start date
2009-04-01
Primary completion
2010-02-01
Completion
2010-03-01
First posted
2009-01-23
Last updated
2015-04-22

Source: ClinicalTrials.gov record NCT00828269. Inclusion in this directory is not an endorsement.

Evaluation of RNA From the Liver Tissue Obtained in Patients With Chronic Hepatitis C (0000-123) (NCT00828269) · Clinical Trials Directory